Company page

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. The company has a market capitalization of approximately $480.79 million. Ginkgo Bioworks specializes in using biotechnology to design custom microbes for various applications across different industries.

DNA:NYSEUpdated July 31, 2026
Ginkgo Bioworks Holdings, Inc. logo
Ticker
DNA:NYSE
Asset type
Stock
Market cap
$528.5M
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
NYSE
Currency
USD